INSP
Income statement / Annual
Last year (2024), Inspire Medical Systems, Inc.'s total revenue was $802.80 M,
an increase of 28.49% from the previous year.
In 2024, Inspire Medical Systems, Inc.'s net income was $53.51 M.
See Inspire Medical Systems, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$802.80 M |
$624.80 M |
$407.86 M |
$233.39 M |
$115.38 M |
$82.05 M |
$50.59 M |
$28.57 M |
$16.43 M |
$8.01 M |
| Cost of Revenue |
$122.99 M
|
$96.58 M
|
$66.12 M
|
$33.28 M
|
$17.62 M
|
$13.64 M
|
$10.06 M
|
$6.02 M
|
$3.91 M
|
$2.81 M
|
| Gross Profit |
$679.82 M
|
$528.22 M
|
$341.74 M
|
$200.12 M
|
$97.76 M
|
$68.41 M
|
$40.54 M
|
$22.55 M
|
$12.52 M
|
$5.20 M
|
| Gross Profit Ratio |
0.85
|
0.85
|
0.84
|
0.86
|
0.85
|
0.83
|
0.8
|
0.79
|
0.76
|
0.65
|
| Research and Development Expenses |
$114.13 M
|
$116.54 M
|
$68.65 M
|
$37.35 M
|
$26.09 M
|
$12.84 M
|
$7.39 M
|
$6.19 M
|
$7.09 M
|
$7.08 M
|
| General & Administrative Expenses |
$434.71 M
|
$351.66 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$44.23 M
|
$3.81 M
|
$19.28 M
|
$2.63 M
|
| Selling & Marketing Expenses |
$94.90 M
|
$100.30 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$9.30 M
|
$28.55 M
|
$3.40 M
|
$15.29 M
|
| Selling, General & Administrative Expenses |
$529.61 M
|
$451.96 M
|
$320.69 M
|
$202.62 M
|
$127.87 M
|
$90.47 M
|
$53.53 M
|
$32.36 M
|
$22.68 M
|
$17.92 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$16.00 K
|
$42.00 K
|
-$29.00 K
|
-$41.00 K
|
| Operating Expenses |
$643.74 M
|
$568.49 M
|
$389.33 M
|
$239.97 M
|
$153.97 M
|
$103.30 M
|
$60.92 M
|
$38.55 M
|
$29.78 M
|
$25.00 M
|
| Cost And Expenses |
$766.72 M
|
$665.07 M
|
$455.45 M
|
$273.24 M
|
$171.59 M
|
$116.95 M
|
$70.97 M
|
$44.57 M
|
$33.68 M
|
$27.81 M
|
| Interest Income |
$23.25 M
|
$20.56 M
|
$5.05 M
|
$125.00 K
|
$1.09 M
|
$3.80 M
|
$1.87 M
|
$203.00 K
|
$57.00 K
|
$66.00 K
|
| Interest Expense |
$22.00 K
|
$0.00
|
$1.68 M
|
$2.13 M
|
$2.12 M
|
$2.12 M
|
$3.30 M
|
$1.75 M
|
$1.30 M
|
$1.56 M
|
| Depreciation & Amortization |
$6.55 M
|
$2.85 M
|
$1.86 M
|
$1.22 M
|
$840.00 K
|
$495.00 K
|
$393.00 K
|
$285.00 K
|
$103.00 K
|
$120.00 K
|
| EBITDA |
$65.03 M |
-$17.06 M |
-$40.73 M |
-$38.62 M |
-$54.13 M |
-$30.59 M |
-$18.13 M |
-$15.47 M |
-$17.12 M |
-$19.65 M |
| EBITDA Ratio |
0.08
|
-0.03
|
-0.1
|
-0.17
|
-0.47
|
-0.37
|
-0.36
|
-0.54
|
-1.04
|
-2.45
|
| Operating Income Ratio |
0.04
|
-0.06
|
-0.12
|
-0.17
|
-0.49
|
-0.43
|
-0.4
|
-0.56
|
-1.05
|
-2.47
|
| Total Other Income/Expenses Net |
$22.37 M
|
$20.37 M
|
$3.32 M
|
-$2.12 M
|
-$880.00 K
|
$1.69 M
|
-$1.45 M
|
-$1.51 M
|
-$1.28 M
|
-$1.54 M
|
| Income Before Tax |
$58.45 M
|
-$19.91 M
|
-$44.27 M
|
-$41.97 M
|
-$57.09 M
|
-$33.20 M
|
-$21.83 M
|
-$17.51 M
|
-$18.53 M
|
-$21.34 M
|
| Income Before Tax Ratio |
0.07
|
-0.03
|
-0.11
|
-0.18
|
-0.49
|
-0.4
|
-0.43
|
-0.61
|
-1.13
|
-2.66
|
| Income Tax Expense |
$4.94 M
|
$1.25 M
|
$613.00 K
|
$72.00 K
|
$115.00 K
|
$40.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
$53.51 M
|
-$21.15 M
|
-$44.88 M
|
-$42.04 M
|
-$57.20 M
|
-$33.24 M
|
-$21.83 M
|
-$17.51 M
|
-$18.53 M
|
-$21.34 M
|
| Net Income Ratio |
0.07
|
-0.03
|
-0.11
|
-0.18
|
-0.5
|
-0.41
|
-0.43
|
-0.61
|
-1.13
|
-2.66
|
| EPS |
1.8 |
-0.72 |
-1.6 |
-1.54 |
-2.19 |
-1.4 |
-1.5 |
-1.3 |
-1.49 |
-1.71 |
| EPS Diluted |
1.75 |
-0.72 |
-1.6 |
-1.54 |
-2.19 |
-1.4 |
-1.5 |
-1.3 |
-1.49 |
-1.71 |
| Weighted Average Shares Out |
$29.76 M
|
$29.30 M
|
$28.07 M
|
$27.26 M
|
$26.07 M
|
$23.80 M
|
$14.58 M
|
$13.49 M
|
$12.46 M
|
$12.46 M
|
| Weighted Average Shares Out Diluted |
$30.54 M
|
$29.30 M
|
$28.07 M
|
$27.26 M
|
$26.07 M
|
$23.80 M
|
$14.58 M
|
$13.49 M
|
$12.46 M
|
$12.46 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
